Clinical trial
VIDAS® NEPHROCLEAR CCL14 Diagnostic Accuracy Study
NCT06036758 is registered in ClinicalTrials.gov with BioMérieux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VIDAS® NEPHROCLEAR CCL14 Diagnostic Accuracy Study
- Lead sponsor
- BioMérieux
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 17, 2023
- Completion date
- December 28, 2023
- Enrollment
- 477 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, stage 2 acute kidney injury, stage 3 acute kidney injury